In silico prioritization and further functional characterization of SPINK1 intronic variants

Abstract Background SPINK1 (serine protease inhibitor, kazal-type, 1), which encodes human pancreatic secretory trypsin inhibitor, is one of the most extensively studied genes underlying chronic pancreatitis. Recently, based upon data from qualitative reverse transcription-PCR (RT-PCR) analyses of t...

Full description

Bibliographic Details
Main Authors: Wen-Bin Zou, Hao Wu, Arnaud Boulling, David N. Cooper, Zhao-Shen Li, Zhuan Liao, Jian-Min Chen, Claude Férec
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Human Genomics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40246-017-0103-9
id doaj-6d6d431cedb1429eb7ebabe149eacc44
record_format Article
spelling doaj-6d6d431cedb1429eb7ebabe149eacc442020-11-25T00:41:11ZengBMCHuman Genomics1479-73642017-05-011111710.1186/s40246-017-0103-9In silico prioritization and further functional characterization of SPINK1 intronic variantsWen-Bin Zou0Hao Wu1Arnaud Boulling2David N. Cooper3Zhao-Shen Li4Zhuan Liao5Jian-Min Chen6Claude Férec7Department of Gastroenterology, Changhai Hospital, Second Military Medical UniversityDepartment of Gastroenterology, Changhai Hospital, Second Military Medical UniversityInstitut National de la Santé et de la Recherche Médicale (INSERM)Institute of Medical Genetics, School of Medicine, Cardiff UniversityDepartment of Gastroenterology, Changhai Hospital, Second Military Medical UniversityDepartment of Gastroenterology, Changhai Hospital, Second Military Medical UniversityInstitut National de la Santé et de la Recherche Médicale (INSERM)Institut National de la Santé et de la Recherche Médicale (INSERM)Abstract Background SPINK1 (serine protease inhibitor, kazal-type, 1), which encodes human pancreatic secretory trypsin inhibitor, is one of the most extensively studied genes underlying chronic pancreatitis. Recently, based upon data from qualitative reverse transcription-PCR (RT-PCR) analyses of transfected HEK293T cells, we concluded that 24 studied SPINK1 intronic variants were not of pathological significance, the sole exceptions being two canonical splice site variants (i.e., c.87 + 1G > A and c.194 + 2T > C). Herein, we employed the splicing prediction tools included within the Alamut software suite to prioritize the ‘non-pathological’ SPINK1 intronic variants for further quantitative RT-PCR analysis. Results Although our results demonstrated the utility of in silico prediction in classifying and prioritizing intronic variants, we made two observations worth noting. First, we established that most of the prediction tools employed ignored the general rule that GC is a weaker donor splice site than the canonical GT site. This finding is potentially important because for a given disease gene, a GC variant donor splice site may be associated with a milder clinical manifestation. Second, the non-pathological c.194 + 13T > G variant was consistently predicted by different programs to generate a new and viable donor splice site, the prediction scores being comparable to those for the physiological c.194 + 2T donor splice site and even higher than those for the physiological c.87 + 1G donor splice site. We do however provide convincing in vitro evidence that the predicted donor splice site was not entirely spurious. Conclusions Our findings, taken together, serve to emphasize the importance of functional analysis in helping to establish or refute the pathogenicity of specific intronic variants.http://link.springer.com/article/10.1186/s40246-017-0103-9Aberrant mRNA transcriptsChronic pancreatitisIn silicoIntronic variantsNon-canonical splice sitesQuantitative RT-PCR analysis
collection DOAJ
language English
format Article
sources DOAJ
author Wen-Bin Zou
Hao Wu
Arnaud Boulling
David N. Cooper
Zhao-Shen Li
Zhuan Liao
Jian-Min Chen
Claude Férec
spellingShingle Wen-Bin Zou
Hao Wu
Arnaud Boulling
David N. Cooper
Zhao-Shen Li
Zhuan Liao
Jian-Min Chen
Claude Férec
In silico prioritization and further functional characterization of SPINK1 intronic variants
Human Genomics
Aberrant mRNA transcripts
Chronic pancreatitis
In silico
Intronic variants
Non-canonical splice sites
Quantitative RT-PCR analysis
author_facet Wen-Bin Zou
Hao Wu
Arnaud Boulling
David N. Cooper
Zhao-Shen Li
Zhuan Liao
Jian-Min Chen
Claude Férec
author_sort Wen-Bin Zou
title In silico prioritization and further functional characterization of SPINK1 intronic variants
title_short In silico prioritization and further functional characterization of SPINK1 intronic variants
title_full In silico prioritization and further functional characterization of SPINK1 intronic variants
title_fullStr In silico prioritization and further functional characterization of SPINK1 intronic variants
title_full_unstemmed In silico prioritization and further functional characterization of SPINK1 intronic variants
title_sort in silico prioritization and further functional characterization of spink1 intronic variants
publisher BMC
series Human Genomics
issn 1479-7364
publishDate 2017-05-01
description Abstract Background SPINK1 (serine protease inhibitor, kazal-type, 1), which encodes human pancreatic secretory trypsin inhibitor, is one of the most extensively studied genes underlying chronic pancreatitis. Recently, based upon data from qualitative reverse transcription-PCR (RT-PCR) analyses of transfected HEK293T cells, we concluded that 24 studied SPINK1 intronic variants were not of pathological significance, the sole exceptions being two canonical splice site variants (i.e., c.87 + 1G > A and c.194 + 2T > C). Herein, we employed the splicing prediction tools included within the Alamut software suite to prioritize the ‘non-pathological’ SPINK1 intronic variants for further quantitative RT-PCR analysis. Results Although our results demonstrated the utility of in silico prediction in classifying and prioritizing intronic variants, we made two observations worth noting. First, we established that most of the prediction tools employed ignored the general rule that GC is a weaker donor splice site than the canonical GT site. This finding is potentially important because for a given disease gene, a GC variant donor splice site may be associated with a milder clinical manifestation. Second, the non-pathological c.194 + 13T > G variant was consistently predicted by different programs to generate a new and viable donor splice site, the prediction scores being comparable to those for the physiological c.194 + 2T donor splice site and even higher than those for the physiological c.87 + 1G donor splice site. We do however provide convincing in vitro evidence that the predicted donor splice site was not entirely spurious. Conclusions Our findings, taken together, serve to emphasize the importance of functional analysis in helping to establish or refute the pathogenicity of specific intronic variants.
topic Aberrant mRNA transcripts
Chronic pancreatitis
In silico
Intronic variants
Non-canonical splice sites
Quantitative RT-PCR analysis
url http://link.springer.com/article/10.1186/s40246-017-0103-9
work_keys_str_mv AT wenbinzou insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants
AT haowu insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants
AT arnaudboulling insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants
AT davidncooper insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants
AT zhaoshenli insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants
AT zhuanliao insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants
AT jianminchen insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants
AT claudeferec insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants
_version_ 1725286922918559744